Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.73 USD | -3.37% | -13.26% | -9.90% |
Mar. 19 | Transcript : Relmada Therapeutics, Inc., 2023 Earnings Call, Mar 19, 2024 | |
Mar. 19 | Relmada Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.90% | 116M | |
-1.65% | 104B | |
+1.86% | 97.42B | |
+0.73% | 22.2B | |
-17.08% | 21.23B | |
-10.51% | 18.33B | |
-42.33% | 16.35B | |
-17.96% | 15.06B | |
+4.96% | 13.98B | |
+27.24% | 11.66B |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Sector Update: Health Care Rises with Broader Thursday Markets